<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">34408742</PMID><DateRevised><Year>2021</Year><Month>08</Month><Day>20</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1664-302X</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><PubDate><Year>2021</Year></PubDate></JournalIssue><Title>Frontiers in microbiology</Title><ISOAbbreviation>Front Microbiol</ISOAbbreviation></Journal><ArticleTitle>Chronic SARS-CoV-2, a Cause of Post-acute COVID-19 Sequelae (Long-COVID)?</ArticleTitle><Pagination><StartPage>724654</StartPage><MedlinePgn>724654</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">724654</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fmicb.2021.724654</ELocationID><Abstract><AbstractText>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause coronavirus disease 2019 (COVID-19). Most individuals recover from SARS-CoV-2 infection, however, many continue to experience a cluster of persistent symptoms for months following resolution of acute disease; a syndrome that has been named Long-COVID. While the biological cause, or causes, of Long-COVID have not yet been confirmed, the main proposals have centred around either virus-induced autoimmunity or virus-induced tissue dysfunction. However, an alternative suggestion that a latent chronic infection could be responsible for the symptoms of Long-COVID has received minimal attention despite recent findings that SARS-CoV-2 genetic material and infections are detected in some individuals months following resolution of respiratory disease. Here we discuss literature supporting the possibility that Long-COVID occurs as a result of chronic SARS-CoV-2 infections.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 O&#x2019;Donnell and Chappell.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>O'Donnell</LastName><ForeName>Jake S</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, QLD, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Australian Institute for Biotechnology and Nanotechnology, The University of Queensland, St Lucia, QLD, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chappell</LastName><ForeName>Keith J</ForeName><Initials>KJ</Initials><AffiliationInfo><Affiliation>School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, QLD, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Australian Institute for Biotechnology and Nanotechnology, The University of Queensland, St Lucia, QLD, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Australian Infectious Disease Research Centre, The University of Queensland, St Lucia, QLD, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>08</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Microbiol</MedlineTA><NlmUniqueID>101548977</NlmUniqueID><ISSNLinking>1664-302X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Long-COVID-syndrome</Keyword><Keyword MajorTopicYN="N">chronic</Keyword><Keyword MajorTopicYN="N">gut flora</Keyword><Keyword MajorTopicYN="N">immunology</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>6</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>7</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>8</Month><Day>19</Day><Hour>6</Hour><Minute>40</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>8</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>20</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>8</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34408742</ArticleId><ArticleId IdType="pmc">PMC8365243</ArticleId><ArticleId IdType="doi">10.3389/fmicb.2021.724654</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ahlawat S., Asha, Sharma K. K. (2020). Immunological co-ordination between gut and lungs in SARS-CoV-2 infection. Virus Res. 286:198103. 10.1016/j.virusres.2020.198103</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2020.198103</ArticleId><ArticleId IdType="pmc">PMC7380259</ArticleId><ArticleId IdType="pubmed">32717345</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z., Xie Y., Bowe B. (2021). High-dimensional characterization of post-acute sequalae of COVID-19. Nature 594 259&#x2013;264. 10.1038/s41586-021-03553-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03553-9</ArticleId><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold D., Milne A., Samms E., Stadon L., Maskell N., Hamilton F. (2021). Are vaccines safe in patients with Long COVID? A prospective observational study. medRxiv [preprint] 10.1101/2021.03.11.21253225</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.03.11.21253225</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashraf U. M., Abokor A. A., Edwards J. M., Waigi E. W., Royfman R. S., Hasan S. A., et al. (2021). SARS-CoV-2, ACE2 expression, and systemic organ invasion. Physiol. Genomics 53 51&#x2013;60. 10.1152/physiolgenomics.00087.2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physiolgenomics.00087.2020</ArticleId><ArticleId IdType="pmc">PMC7900915</ArticleId><ArticleId IdType="pubmed">33275540</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastard P., Rosen L. B., Zhang Q., Michailidis E., Hoffmann H. H., Zhang Y., et al. (2020). Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science 370:eabd4585.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7857397</ArticleId><ArticleId IdType="pubmed">32972996</ArticleId></ArticleIdList></Reference><Reference><Citation>Belluck P. (2021). Some Long Covid Patients Feel Much Better After Getting the Vaccine. New York, NY: The New York Times.</Citation></Reference><Reference><Citation>Beyerstedt S., Casaro E. B., Rangel &#xc9;. B. (2021). COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection. Eur. J. Clin. Microbiol. Infect. Dis. 40 905&#x2013;919. 10.1007/s10096-020-04138-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10096-020-04138-6</ArticleId><ArticleId IdType="pmc">PMC7778857</ArticleId><ArticleId IdType="pubmed">33389262</ArticleId></ArticleIdList></Reference><Reference><Citation>Blacklow N. R., Cukor G. (1981). Viral gastroenteritis. New Eng. J. Med. 304 397&#x2013;406.</Citation><ArticleIdList><ArticleId IdType="pubmed">6256628</ArticleId></ArticleIdList></Reference><Reference><Citation>Bogler A., Packman A., Furman A., Gross A., Kushmaro A., Ronen A., et al. (2020). Rethinking wastewater risks and monitoring in light of the COVID-19 pandemic. Nat. Sustainabil. 3 981&#x2013;990.</Citation></Reference><Reference><Citation>Braun F., L&#xfc;tgehetmann M., Pfefferle S., Wong M. N., Carsten A., Lindenmeyer M. T., et al. (2020). SARS-CoV-2 renal tropism associates with acute kidney injury. Lancet 396 597&#x2013;598. 10.1016/s0140-6736(20)31759-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(20)31759-1</ArticleId><ArticleId IdType="pmc">PMC7431179</ArticleId><ArticleId IdType="pubmed">32818439</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown E. M., Kenny D. J., Xavier R. J. (2019). Gut microbiota regulation of T cells during inflammation and autoimmunity. Ann. Rev. Immunol. 37 599&#x2013;624. 10.1146/annurev-immunol-042718-041841</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-immunol-042718-041841</ArticleId><ArticleId IdType="pubmed">31026411</ArticleId></ArticleIdList></Reference><Reference><Citation>Ca&#xf1;as C. A. (2020). The triggering of post-COVID-19 autoimmunity phenomena could be associated with both transient immunosuppression and an inappropriate form of immune reconstitution in susceptible individuals. Med. Hypotheses 145:110345. 10.1016/j.mehy.2020.110345</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2020.110345</ArticleId><ArticleId IdType="pmc">PMC7556280</ArticleId><ArticleId IdType="pubmed">33080459</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A., Bernabei R., Landi F.Gemelli Against Covid-19 Post-Acute Care Study Group (2020). Persistent symptoms in patients after acute COVID-19. JAMA 324 603&#x2013;605. 10.1001/jama.2020.12603</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Chowdhury M. A., Hossain N., Kashem M. A., Shahid M. A., Alam A. (2020). Immune response in COVID-19: a review. J. Infect. Public Health 13 1619&#x2013;1629.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7359800</ArticleId><ArticleId IdType="pubmed">32718895</ArticleId></ArticleIdList></Reference><Reference><Citation>Crow M. K., Olferiev M., Kirou K. A. (2019). Type I Interferons in autoimmune Disease. Ann. Rev. Pathol. Mechan. Dis. 14 369&#x2013;393. 10.1146/annurev-pathol-020117-043952</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-pathol-020117-043952</ArticleId><ArticleId IdType="pubmed">30332560</ArticleId></ArticleIdList></Reference><Reference><Citation>Deriu E., Boxx G. M., He X., Pan C., Benavidez S. D., Cen L., et al. (2016). Influenza virus affects intestinal microbiota and secondary Salmonella infection in the gut through Type I interferons. PLoS Pathog 12:e1005572. 10.1371/journal.ppat.1005572</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1005572</ArticleId><ArticleId IdType="pmc">PMC4858270</ArticleId><ArticleId IdType="pubmed">27149619</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong M., Zhang J., Ma X., Tan J., Chen L., Liu S., et al. (2020). ACE2, TMPRSS2 distribution and extrapulmonary organ injury in patients with COVID-19. Biomed. Pharmacotherapy 131:110678. 10.1016/j.biopha.2020.110678</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2020.110678</ArticleId><ArticleId IdType="pmc">PMC7444942</ArticleId><ArticleId IdType="pubmed">32861070</ArticleId></ArticleIdList></Reference><Reference><Citation>Doykov I., H&#xe4;llqvist J., Gilmour K. C., Grandjean L., Mills K., Heywood W. E. (2020). &#x2018;The long tail of Covid-19&#x2019; - The detection of a prolonged inflammatory response after a SARS-CoV-2 infection in asymptomatic and mildly affected patients. F1000Res 9:1349. 10.12688/f1000research.27287.1</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/f1000research.27287.1</ArticleId><ArticleId IdType="pmc">PMC7745182</ArticleId><ArticleId IdType="pubmed">33391730</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaebler C., Wang Z., Lorenzi J. C. C., Muecksch F., Finkin S., Tokuyama M., et al. (2021). Evolution of antibody immunity to SARS-CoV-2. Nature 591 639&#x2013;644.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8221082</ArticleId><ArticleId IdType="pubmed">33461210</ArticleId></ArticleIdList></Reference><Reference><Citation>Groves H. T., Higham S. L., Moffatt M. F., Cox M. J., Tregoning J. S. (2020). Respiratory viral infection alters the gut microbiota by inducing inappetence. mBio 11:e03236-19. 10.1128/mBio.03236-19</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.03236-19</ArticleId><ArticleId IdType="pmc">PMC7029140</ArticleId><ArticleId IdType="pubmed">32071269</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta A., Madhavan M. V., Sehgal K., Nair N., Mahajan S., Sehrawat T. S., et al. (2020). Extrapulmonary manifestations of COVID-19. Nat. Med. 26 1017&#x2013;1032.</Citation><ArticleIdList><ArticleId IdType="pubmed">32651579</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadjadj J., Yatim N., Barnabei L., Corneau A., Boussier J., Smith N., et al. (2020). Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science 369 718&#x2013;724.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7402632</ArticleId><ArticleId IdType="pubmed">32661059</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M., Kleine-Weber H., Schroeder S., Kr&#xfc;ger N., Herrler T., Erichsen S., et al. (2020). SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181 271&#x2013;280.e8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Huang L., Wang Y., Li X., Ren L., Gu X., et al. (2021). 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet 397 220&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamers M. M., Beumer J., van der Vaart J., Knoops K., Puschhof J., Breugem T. I., et al. (2020). SARS-CoV-2 productively infects human gut enterocytes. Science 369 50&#x2013;54. 10.1126/science.abc1669</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abc1669</ArticleId><ArticleId IdType="pmc">PMC7199907</ArticleId><ArticleId IdType="pubmed">32358202</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J. S., Shin E.-C. (2020). The type I interferon response in COVID-19: implications for treatment. Nat. Rev. Immunol. 20 585&#x2013;586. 10.1038/s41577-020-00429-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-00429-3</ArticleId><ArticleId IdType="pmc">PMC8824445</ArticleId><ArticleId IdType="pubmed">32788708</ArticleId></ArticleIdList></Reference><Reference><Citation>Leisman D. E., Ronner L., Pinotti R., Taylor M. D., Sinha P., Calfee C. S., et al. (2020). Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes. Lancet Respiratory Med. 8 1233&#x2013;1244. 10.1016/s2213-2600(20)30404-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s2213-2600(20)30404-5</ArticleId><ArticleId IdType="pmc">PMC7567529</ArticleId><ArticleId IdType="pubmed">33075298</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucas C., Wong P., Klein J., Castro T. B. R., Silva J., Sundaram M., et al. (2020). Longitudinal analyses reveal immunological misfiring in severe COVID-19. Nature 584 463&#x2013;469.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7477538</ArticleId><ArticleId IdType="pubmed">32717743</ArticleId></ArticleIdList></Reference><Reference><Citation>McNab F., Mayer-Barber K., Sher A., Wack A., O&#x2019;Garra A. (2015). Type I interferons in infectious disease. Nat. Rev. Immunol. 15 87&#x2013;103. 10.1038/nri3787</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri3787</ArticleId><ArticleId IdType="pmc">PMC7162685</ArticleId><ArticleId IdType="pubmed">25614319</ArticleId></ArticleIdList></Reference><Reference><Citation>Puelles V. G., L&#xfc;tgehetmann M., Lindenmeyer M. T., Sperhake J. P., Wong M. N., Allweiss L., et al. (2020). Multiorgan and renal tropism of SARS-CoV-2. N. Engl. J. Med. 383 590&#x2013;592.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7240771</ArticleId><ArticleId IdType="pubmed">32402155</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramakrishna C., Kujawski M., Chu H., Li L., Mazmanian S. K., Cantin E. M. (2019). Bacteroides fragilis polysaccharide A induces IL-10 secreting B and T cells that prevent viral encephalitis. Nat. Commun. 10:2153.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6517419</ArticleId><ArticleId IdType="pubmed">31089128</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen H. R. (2011). Chronic hepatitis C infection. New Eng. J. Med. 364 2429&#x2013;2438.</Citation><ArticleIdList><ArticleId IdType="pubmed">21696309</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt M. E., Varga S. M. (2018). The CD8 T cell response to respiratory virus infections. Front. Immunol. 9:678. 10.3389/fimmu.2018.00678</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.00678</ArticleId><ArticleId IdType="pmc">PMC5900024</ArticleId><ArticleId IdType="pubmed">29686673</ArticleId></ArticleIdList></Reference><Reference><Citation>Sencio V., Machado M. G., Trottein F. (2021). The lung&#x2013;gut axis during viral respiratory infections: the impact of gut dysbiosis on secondary disease outcomes. Mucosal Immunol. 14 296&#x2013;304. 10.1038/s41385-020-00361-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41385-020-00361-8</ArticleId><ArticleId IdType="pmc">PMC7835650</ArticleId><ArticleId IdType="pubmed">33500564</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeoh Y. K., Zuo T., Lui G. C.-Y., Zhang F., Liu Q., Li A. Y., et al. (2021). Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19. Gut 70 698&#x2013;706. 10.1136/gutjnl-2020-323020</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2020-323020</ArticleId><ArticleId IdType="pmc">PMC7804842</ArticleId><ArticleId IdType="pubmed">33431578</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng D., Liwinski T., Elinav E. (2020). Interaction between microbiota and immunity in health and disease. Cell Res. 30 492&#x2013;506. 10.1038/s41422-020-0332-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41422-020-0332-7</ArticleId><ArticleId IdType="pmc">PMC7264227</ArticleId><ArticleId IdType="pubmed">32433595</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong P., Xu J., Yang D., Shen Y., Wang L., Feng Y., et al. (2020). COVID-19-associated gastrointestinal and liver injury: clinical features and potential mechanisms. Signal Trans. Targeted Therapy 5:256.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7605138</ArticleId><ArticleId IdType="pubmed">33139693</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>